Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Biochem Cell Biol ; 96(2): 107-116, 2018 04.
Article in English | MEDLINE | ID: mdl-29112458

ABSTRACT

In western countries, alcohol consumption is widespread in women of reproductive age, and in binge quantities. These countries also continue to have high incidences of unplanned pregnancies, with women often reported to cease drinking after discovering their pregnancy. This suggests the early embryo may be highly exposed to the detrimental effects of alcohol during the periconception period. The periconception and pre-implantation windows, which include maturation of the oocyte, fertilisation, and morphogenesis of the pre-implantation embryo, are particularly sensitive times of development. Within the oviduct and uterus, the embryo is exposed to a unique nutritional environment to facilitate its development and establish de-novo expression of the genome through epigenetic reprogramming. Alcohol has wide-ranging effects on cellular stress, as well as hormonal, and nutrient signalling pathways, which may affect the development and metabolism of the early embryo. In this review, we summarise the adverse developmental outcomes of early exposure to alcohol (prior to implantation in animal models) and discuss the potential mechanisms for these outcomes that may occur within the protected oviductal and uterine environment. One interesting candidate is reduced retinoic acid synthesis, as it is implicated in the control of epigenetic reprogramming and cell lineage commitment, processes that have adverse consequences for the formation of the placenta, and subsequently, fetal programming.


Subject(s)
Alcohol Drinking/adverse effects , Blastocyst , Embryonic Development , Epigenesis, Genetic , Fertilization , Gene Expression Regulation, Developmental , Animals , Female , Humans , Male
2.
Biol Sex Differ ; 8: 17, 2017.
Article in English | MEDLINE | ID: mdl-28523122

ABSTRACT

BACKGROUND: A male fetus is suggested to be more susceptible to in utero and birth complications. This may be due in part to altered morphology or function of the XY placenta. We hypothesised that sexual dimorphism begins at the blastocyst stage with sex differences in the progenitor trophectoderm (TE) and its derived trophoblast lineages, as these cells populate the majority of cell types within the placenta. We investigated sex-specific differences in cell allocation in the pre-implantation embryo and further characterised growth and gene expression of the placental compartments from the early stages of the definitive placenta through to late gestation. METHODS: Naturally mated Sprague Dawley dams were used to collect blastocysts at embryonic day (E) 5 to characterise cell allocation; total, TE, and inner cell mass (ICM), and differentiation to downstream trophoblast cell types. Placental tissues were collected at E13, E15, and E20 to characterise volumes of placental compartments, and sex-specific gene expression profiles. RESULTS: Pre-implantation embryos showed no sex differences in cell allocation (total, TE and ICM) or early trophoblast differentiation, assessed by outgrowth area, number and ploidy of trophoblasts and P-TGCs, and expression of markers of trophoblast stem cell state or differentiation. Whilst no changes in placental structures were found in the immature E13 placenta, the definitive E15 placenta from female fetuses had reduced labyrinthine volume, fetal and maternal blood space volume, as well as fetal blood space surface area, when compared to placentas from males. No differences between the sexes in labyrinth trophoblast volume or interhaemal membrane thickness were found. By E20 these sex-specific placental differences were no longer present, but female fetuses weighed less than their male counterparts. Coupled with expression profiles from E13 and E15 placental samples may suggest a developmental delay in placental differentiation. CONCLUSIONS: Although there were no overt differences in blastocyst cell number or early placental development, reduced growth of the female labyrinth in mid gestation is likely to contribute to lower fetal weight in females at E20. These data suggest sex differences in fetal growth trajectories are due at least in part, to differences in placenta growth.


Subject(s)
Placenta/embryology , Placentation , Sex Characteristics , Animals , Cell Count , Cell Differentiation , Chorionic Villi/embryology , Chorionic Villi/metabolism , Embryo Implantation , Female , Gestational Age , Male , Placenta/cytology , Placenta/metabolism , Pregnancy , RNA, Messenger/metabolism , Rats, Sprague-Dawley
3.
Placenta ; 54: 10-16, 2017 06.
Article in English | MEDLINE | ID: mdl-27979377

ABSTRACT

Exposure of the embryo or fetus to perturbations in utero can result in intrauterine growth restriction, a primary risk factor for the development of adult disease. However, despite similar exposures, males and females often have altered disease susceptibility or progression from different stages of life. Fetal growth is largely mediated by the placenta, which, like the fetus is genetically XX or XY. The placenta and its associated trophoblast lineages originate from the trophectoderm (TE) of the early embryo. Rodent models (rat, mouse, spiny mouse), have been used extensively to examine placenta development and these have demonstrated the growth trajectory of the placenta in females is generally slower compared to males, and also shows altered adaptive responses to stressful environments. These placental adaptations are likely to depend on the type of stressor, duration, severity and the window of exposure during development. Here we describe the divergent developmental pathways between the male and female placenta contributing to altered differentiation of the TE derived trophoblast subtypes, placental growth, and formation of the placental architecture. Our focus is primarily genetic or environmental perturbations in rodent models which show altered placental responsiveness between sexes. We suggest that perturbations during early placental development may have greater impact on viability and growth of the female fetus whilst those occurring later in gestation may preferentially affect the male fetus. This may be of great relevance to human pregnancies which result from assisted reproductive technologies or complications such as pre-eclampsia and diabetes.


Subject(s)
Placenta/physiology , Placentation , Sex Characteristics , Animals , Female , Humans , Placenta/blood supply , Pregnancy
4.
Placenta ; 46: 87-91, 2016 10.
Article in English | MEDLINE | ID: mdl-27697226

ABSTRACT

Maternal alcohol consumption is common prior to pregnancy recognition and in the rat results in altered placental development and fetal growth restriction. To assess the effect of ethanol (EtOH) exposure on the differentiation of trophoblast stem (TS) cells, mouse TS lines were differentiated in vitro for 6 days in 0%, 0.2% or 1% EtOH. This reduced both trophoblast survival and expression of labyrinth and junctional zone trophoblast subtype-specific genes. This suggests that fetal growth restriction and altered placental development associated with maternal alcohol consumption in the periconceptional period could be mediated in part by direct effects on trophoblast development.


Subject(s)
Central Nervous System Depressants/toxicity , Ethanol/toxicity , Pregnancy Proteins/metabolism , Trophoblasts/drug effects , Animals , Biomarkers/metabolism , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Gene Expression/drug effects , Mice , Trophoblasts/metabolism
5.
Immunopharmacology ; 43(2-3): 265-71, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10596862

ABSTRACT

This study is part of a project aimed at understanding individual responses to acute endotoxemia in a catheter-free rhesus (Macaca mulatta) model of inflammation. In the previous study [J. Endotoxin Res. 2 (1995) 411-420.], we showed that of 14 endotoxin 0111:B4 (ETX)-infused monkeys, only three died at < 13.5 h and one at 6 days postinfusion. Doses of ETX correlated neither with the magnitude of hypotension nor with rhesus outcome. Survival (and death at 6 days) or death at < 13.5 h was rather associated with controllable or uncontrollable rise of plasma levels of proinflammatory cytokines and reversible or irreversible shock. In the current study, we used plasmas of 5 survivors and of one of the monkeys that died at < 13.5 h (each infused with 3 X 10(6) EU ETX/kg), and of two saline control monkeys of the previous study. We analyzed changes in parameters of coagulation and contact systems. After ETX infusion, activated partial thromboplastin time (APTT) and prothrombin time (PT) values increased modestly in survivors but markedly in the nonsurvivor; responses of platelet counts and levels of fibrinogen, antithrombin, alpha2-macroglobulin (alpha2M), Cl-inhibitor (C1INH) and alpha1 -antitrypsin were similar in survivors and the nonsurvivor; the rate of plasma prekallikrein (PK) activation measured by hydrolysis of the kallikrein (KAL) substrate D-Pro-Phe-Arg-p-nitroanilide was not altered by ETX infusion; and the distribution of PK activation products, analyzed by MAb 13G11/immunoblotting in plasmas with or without artificial activation, was similar in survivors and the nonsurvivor. Responses in controls were relatively stable. Since we used defined experimental conditions, this primate model has the potential to be useful to study further correlation of inflammatory parameters with differential outcome.


Subject(s)
Endotoxins/toxicity , Inflammation/blood , Prekallikrein/metabolism , Animals , Macaca mulatta , Partial Thromboplastin Time , Prothrombin Time , Tumor Necrosis Factor-alpha/analysis
6.
Ann Intern Med ; 120(4): 294-9, 1994 Feb 15.
Article in English | MEDLINE | ID: mdl-8291822

ABSTRACT

OBJECTIVE: To determine whether doxycycline, 100 mg administered as a single daily oral dose, is effective as a causal prophylactic agent, an agent active against the pre-erythrocytic liver stage of Plasmodium falciparum malaria parasites, in healthy nonimmune persons. If effective, the recommendation by the Centers for Disease Control and Prevention (CDC) that doxycycline be continued for 4 weeks after returning from malaria-endemic areas could be shortened to 1 week. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: Medical ward at the U.S. Army Research Institute of Infectious Diseases, Fort Detrick, Maryland. PARTICIPANTS: 18 nonimmune, healthy, adult male volunteers, age 21.7 +/- 2.9 (SD) years, were enrolled in two groups, one of 8 persons and one of 10 persons. Six participants in the first group and 7 in the second group received doxycycline. The remaining participants received placebo. Two volunteers were dropped from the study, leaving 16 participants for analysis. INTERVENTION: Each participant received doxycycline, 100 mg, or placebo in a single daily oral dose starting 3 days before exposure to P. falciparum-infected mosquitoes and ending 6 days after exposure. MEASUREMENTS: Monitoring for parasitemia, plasma doxycycline concentrations, and mosquitoes' salivary-gland sporozoite grade. RESULTS: 6 of 6 (100% [95% Cl, 54% to 100%]) participants on doxycycline in the first group and 2 of 6 (33% [Cl, 4% to 78%]) in the second group were protected from malaria. No differences were found between protected and nonprotected participants in the doxycycline elimination half-life (T1/2) (20.8 +/- 5.0 h compared with 21.9 +/- 5.2 h), the steady-state average plasma concentration (1626 +/- 469 ng/mL compared with 1698 +/- 651 ng/mL), or other pharmacokinetic parameter estimates. The mean mosquito salivary-gland sporozoite grade was significantly higher (P = 0.02) in protected (3.5 +/- 0.3) than in nonprotected persons (3.1 +/- 0.1). Overall, 8 of 12 persons on doxycycline were protected from malaria, yielding a causal prophylactic efficacy rate of 67% (Cl, 35% to 90%). CONCLUSIONS: A dosing regimen of doxycycline, 100 mg once daily, administered as a causal prophylactic agent against P. falciparum malaria in healthy, nonimmune volunteers, had an unacceptably high failure rate. Therefore, the CDC recommendation that doxycycline should be taken daily starting 1 to 2 days before travel, during travel, and for 4 weeks after travel should still be followed.


Subject(s)
Doxycycline/administration & dosage , Malaria, Falciparum/prevention & control , Administration, Oral , Adult , Animals , Double-Blind Method , Doxycycline/pharmacokinetics , Drug Administration Schedule , Humans , Immunocompetence , Male
7.
W V Med J ; 89(10): 442-4, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8266681

ABSTRACT

To gauge the impact of screening mammography and the results of clinical trials on the pattern of primary surgical care of early breast cancer, tumor registry data from the Charleston Area Medical Center for 1980-81 was compared to tumor registry data at the hospital for 1990-91. Over the course of 10 years, there was a significant increase in the proportion of patients with T1 tumors (52% vs. 66%, p = .004), a significant increase of cases diagnosed by mammography alone (6% vs. 34%, p < .001), a significant decrease in the proportion of patients with positive axillary nodes (41% vs. 28%, p = .016), and a significant increase in the proportion of patients undergoing breast-sparing procedures (4% vs. 16%, p = .003). However, the percentage of breast-sparing operations at CAMC from 1990-91 was lower than the number reported in the National Cancer Data Base of 1988 (16% vs. 29%). A future study to assess reasons for patient selection of mastectomy or local excision is being planned.


Subject(s)
Breast Neoplasms/epidemiology , Mammography , Mass Screening , Precancerous Conditions/epidemiology , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Breast Neoplasms/prevention & control , Female , Humans , Middle Aged , Neoplasm Staging , Precancerous Conditions/pathology , Precancerous Conditions/prevention & control , Registries/statistics & numerical data , West Virginia/epidemiology
8.
Chin Med J (Engl) ; 106(8): 608-10, 1993 Aug.
Article in English | MEDLINE | ID: mdl-7900974

ABSTRACT

We analysed the early viremia and clinical tests in 82 patients with epidemic hemorrhagic fever (EHF). The results showed that the changes in viremia and clinical tests are related to the severity of the disease and prognosis. Higher concentrations of the virus in infected patients might cause a more unfavourable prognosis and more abnormalities in clinical tests. CK-MB, SGOT, SGPT, serum creatinine and urea nitrogen contents increased markedly, while serum total protein, albumin and calcium contents decreased markedly, indicating that the heart, liver and kidney in EHF patients were severely damaged. Markedly increased WBC and monocytes showed that the patients were seriously infected. Platelet count, antithrombin-III and plasminogen decreased markedly, demonstrating that there were marked changes in the coagulation-anticoagulation and fibrinolytic system of the EHF patients. Changes in RBC, Hb and HCT contents indicated that the blood in the EHF patients had a higher concentration. This study gives further evidence that EHFV plays an important role in the pathogenesis of EHF.


Subject(s)
Creatine Kinase/blood , Hemorrhagic Fever with Renal Syndrome/microbiology , Viremia/blood , Adolescent , Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Female , Hematocrit , Hemorrhagic Fever with Renal Syndrome/blood , Humans , Isoenzymes , Male , Middle Aged , Prognosis
9.
Thromb Haemost ; 68(5): 526-33, 1992 Nov 10.
Article in English | MEDLINE | ID: mdl-1455399

ABSTRACT

To determine if rhesus monkeys (Macaca mulatta) could serve as a model for studying the role of the contact system in the pathophysiology of human infections, we compared structural, kinetic, and functional characteristics of plasma prekallikrein and its activation products in rhesus and humans. Three prekallikrein variants (85-, 89- and 93-kDa) were revealed in rhesus plasma as compared with the two variants (85- and 88-kDa) in human plasma by immunoblotting with the monoclonal antibody MAb 13G11. The prekallikrein concentration in rhesus plasma was 1.5-fold that in human plasma as determined by computerized immunoblot analyses (CIBA) and amidolytic activity. The electrophoretic mobility of prekallikrein from plasma of both species increased after deglycosylation. Inhibition of prekallikrein activation by MAb 13G11 was 55% (rhesus plasma) and 76% (human plasma), with similar inhibition curves. Immunoblots of activated rhesus plasma showed prekallikrein, complexes of kallikrein with C1 inhibitor, alpha 2-macroglobulin and approximately 60-kDa inhibitor(s) (viz. antithrombin III), and 45-kDa fragments, like those in activated human plasma. Concentrations and molecular masses of factor XII and high molecular weight kininogen were similar in rhesus and human plasma. The activated partial thromboplastin time (APTT) and prothrombin time were 20.1 +/- 1.6 and 9.7 +/- 0.3 s for rhesus and 32.0 +/- 5.6 and 12 +/- 0.5 s for human plasma. Human and rhesus APTTs were similar when prekallikrein concentrations in human and rhesus plasma became alike by adding human purified prekallikrein.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Prekallikrein/chemistry , Animals , Factor XII/metabolism , Fibrinogen/metabolism , Glycosylation , Humans , Kallikreins/antagonists & inhibitors , Kinetics , Kininogens/metabolism , Macaca mulatta , Molecular Structure , Partial Thromboplastin Time , Prekallikrein/metabolism , Prekallikrein/pharmacology , Prothrombin Time , Species Specificity , Temperature
10.
J Infect Dis ; 164(6): 1119-27, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1683355

ABSTRACT

A prospective, randomized, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin (loading dose of 33 mg/kg, 16 mg/kg every 6 h for 4 days, and 8 mg/kg every 8 h for 3 days) was conducted in 242 patients with serologically confirmed hemorrhagic fever with renal syndrome (HFRS) in the People's Republic of China. Mortality was significantly reduced (sevenfold decrease in risk) among ribavirin-treated patients, when comparisons were adjusted for baseline risk estimators of mortality (P = .01; two-tailed). HFRS typically consists of five consecutive but frequently overlapping clinical phases. Only occurrence of oliguric phase and hemorrhage was associated with severity of clinical disease in the placebo group. Ribavirin therapy also resulted in a significant reduction in the risk of entering the oliguric phase and experiencing hemorrhage. The only ribavirin-related side effect was a well-recognized, fully reversible anemia after completion of therapy.


Subject(s)
Hemorrhagic Fever with Renal Syndrome/drug therapy , Ribavirin/therapeutic use , Anemia, Hemolytic/chemically induced , Double-Blind Method , Female , Fever/drug therapy , Fever/etiology , Follow-Up Studies , Orthohantavirus/immunology , Hemorrhagic Fever with Renal Syndrome/complications , Hemorrhagic Fever with Renal Syndrome/mortality , Humans , Hypotension/drug therapy , Hypotension/etiology , Immunoglobulin M/blood , Injections, Intravenous , Life Tables , Male , Oliguria/drug therapy , Oliguria/etiology , Polyuria/drug therapy , Polyuria/etiology , Prognosis , Prospective Studies , Regression Analysis , Ribavirin/administration & dosage , Ribavirin/adverse effects
11.
Chin Med J (Engl) ; 104(2): 149-53, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1678691

ABSTRACT

Kinetic changes of viremia were observed in 287 cases of hemorrhagic fever with renal syndrome (HFRS) in whom ribavirin was administered with double blind random control studied by means of virus isolation, indirect immunofluorescence assay and enzyme-linked immunosorbent assay. The positive rate of viremia was 79.7% (Sp = 3%) and positive rate of HERS IgM was 85% (Sp = 3.1%) before treatment. Viremia could be interrupted by ribavirin as in the ribavirin treated group, the viremia positive rate decreased, duration of viremia was shortened, viral antigen products, virus titer and HFRS IgG antibody level were reduced as compared with the control group. This showed that viremia was very frequent in patients in the febrile phase and ribavirin is an effective antiviral drug in HFRS during the febrile phase. Dosage and course of treatment of this drug are discussed.


Subject(s)
Hemorrhagic Fever with Renal Syndrome/drug therapy , Ribavirin/therapeutic use , Viremia/drug therapy , Double-Blind Method , Fever , Humans
12.
Infect Immun ; 58(9): 3056-60, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2387633

ABSTRACT

There appears to be a particular association between Helicobacter pylori and the gastric antrum, but the mechanisms by which the organism adheres to and colonizes the gastric mucosa are unclear. Surface hydrophobicity and surface charge mediate the adherence of other bacterial pathogens to mucosal epithelial cell surfaces. Therefore, in this study we characterized both the surface hydrophobicity and the surface charge of 10 H. pylori strains grown in broth culture. Four complementary methods were used to determine hydrophobicity: hydrophobic interaction chromatography, the salt aggregation test, comparison of bacterial adherence to polystyrene with adherence to sulfonated polystyrene, and measurement of contact angle with droplets of water. Three of the methods (salt aggregation test, adherence to polystyrene, and contact angles) indicated that each of the 10 strains expressed a relatively hydrophilic cell surface. In contrast, hydrophobic interaction chromatography determinations with both phenyl- and octyl-Sepharose suggested that the H. pylori strains were relatively hydrophobic. However, tetramethyl urea (0.4 M) did not reduce the binding of H. pylori to phenyl-Sepharose columns. DEAE-cellulose ion-exchange chromatography showed that each of the 10 strains of H. pylori had a surface which, overall, was highly negatively charged. We conclude that H. pylori expresses an overall relatively hydrophilic and negatively charged surface in vitro.


Subject(s)
Bacterial Adhesion , Campylobacter/physiology , Gastric Mucosa/microbiology , Surface Properties , Epithelium/microbiology , Humans
13.
Lancet ; 1(8629): 68-71, 1989 Jan 14.
Article in English | MEDLINE | ID: mdl-2462660

ABSTRACT

A rapid diagnostic test for malaria based on acridine orange staining of centrifuged parasites in a microhaematocrit tube ('QBC' tube) was compared with the thick blood smear in 12 volunteers experimentally infected with Plasmodium falciparum, 408 residents of a malaria endemic area, and 180 hospital patients with suspected malaria. In the experimentally infected volunteers, the QBC tube test and the thick blood smear were comparable and the QBC tube could detect as few as 4 parasites/microliter blood. When used for mass screening in the field study, the test had a sensitivity of 70% for the diagnosis of malaria compared with 92% for a single thick blood smear. However, when used to diagnose malaria in hospital patients, the test detected as few as 3 parasites/microliter in 91 of 92 patients with asexual parasitaemia. For the three studies, the QBC tube was highly specific (98.4%), indicating malaria in only 8 of 487 subjects with negative blood films. The species of parasite was correctly identified in 77% of species. Processing the QBC tube was easier and much more rapid than was processing a thick blood smear, taking only 5 min for centrifugation and 5 min for examination. The QBC tube is not a substitute for the blood smear, but its speed and ease of use make it an important new tool for the diagnosis of malaria.


Subject(s)
Acridine Orange , Malaria/diagnosis , Parasitology/methods , Plasmodium falciparum/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Centrifugation , Child , Child, Preschool , Evaluation Studies as Topic , Humans , Infant , Malaria/blood , Middle Aged , Parasitology/instrumentation , Predictive Value of Tests , Staining and Labeling/methods , Time Factors
15.
Planta Med ; 53(5): 470-4, 1987 Oct.
Article in English | MEDLINE | ID: mdl-17269070

ABSTRACT

When added to suspension cultures of CATHARANTHUS ROSEUS, abscisic acid (ABA) stimulated intracellular accumulation of the indole alkaloids catharanthine and ajmalicine in both flask and 30 litre fermenter-scale systems. The response varied, and depended upon the cell line, the concentration and source of the ABA, and the growth phase at which the cells were treated. Precise timing of ABA addition to cells in a 301 fermenter resulted in a catharanthine yield of 85.25 mg/l after 10 days of cultivation. We propose that ABA may be useful for increasing the yield and reducing the production time for commercially useful secondary plant metabolites.

16.
Am J Trop Med Hyg ; 36(2): 416-23, 1987 Mar.
Article in English | MEDLINE | ID: mdl-3030150

ABSTRACT

Significant coagulation abnormalities were associated with experimental infection of strain 13 guinea pigs with Pichinde virus, an arenavirus related to the virulent human pathogens Junin, Machupo, and Lassa viruses. Infected animals developed decreased activity of multiple coagulation factors, decreased antithrombin III levels, high levels of fibrin-fibrinogen degradation products, impaired platelet function, and thrombocytopenia. Testing for the presence of a coagulation inhibitor revealed a pattern consistent with factor deficiency. Fibrin thrombi were not found at necropsy. The findings of high fibrin-fibrinogen degradation product levels and decreased antithrombin III levels, in association with decreased activity of multiple coagulation factors and thrombocytopenia, suggest that intravascular coagulation is a feature of this experimental infection. The demonstration of abnormal platelet function is also significant, as this could contribute to defective hemostasis despite the moderate thrombocytopenia which usually occurs in arenaviral disease.


Subject(s)
Arenaviridae Infections/blood , Blood Coagulation Disorders/microbiology , Hemorrhagic Fever, American/blood , Animals , Blood Coagulation Tests , Female , Guinea Pigs , Hemagglutination Inhibition Tests , Hematocrit , Leukocyte Count , Male , Platelet Aggregation , Platelet Count
17.
Pediatr Infect Dis J ; 6(2): 170-6, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3031575

ABSTRACT

During 29 months of prospective longitudinal study of diarrhea in the home, human rotaviruses (HRVs) infected one or more members in 51% of 65 families, 35 of 126 children (28%) and 16 of 124 adults (13%). Within the 33 affected families, 57% of 62 children and 25% of 65 adults were infected. HRV gastroenteritis peaked at 40/100 person years at ages 12 to 23 months and decreased to 5 episodes/100 person years in adults. Among 25 children 0 through 36 months of age who had HRV infection, 88% were symptomatic. Of the 22 children with symptomatic HRV infection, 1 required hospitalization and 8 were seen by their physician for supportive care. HRVs were found in 12% of 216 stools obtained during gastrointestinal illness, but in only 0.2% of 1238 non-illness stools tested. HRV infections were noted as early as October and as late as April. Of 33 families who were studied for 2 seasons, at least 1 individual in each of 3 families experienced HRV infections in both years, but only one, an adult, shed virus and had symptoms in both seasons.


Subject(s)
Gastroenteritis/genetics , Rotavirus Infections/genetics , Adolescent , Adult , Child , Child, Preschool , Enterovirus Infections , Enzyme-Linked Immunosorbent Assay , Feces/microbiology , Female , Gastroenteritis/diagnosis , Gastroenteritis/epidemiology , Gastroenteritis/therapy , Humans , Infant , Longitudinal Studies , Male , Microscopy, Electron , Prospective Studies , Rotavirus/isolation & purification , Rotavirus Infections/diagnosis , Rotavirus Infections/epidemiology , Rotavirus Infections/therapy , Virginia
18.
Plant Cell Rep ; 6(2): 142-5, 1987 Apr.
Article in English | MEDLINE | ID: mdl-24248497

ABSTRACT

Vanadyl sulphate (10-500 mg/l), when added to cell suspension cultures of Catharanthus roseus stimulated increased intracellular accumulation of catharanthine and ajmalicine. This response was demonstrated in both flask and fermenter (30 litre) systems. The response varied, and depended upon cell line, concentration of vanadyl sulphate and the stage of the growth phase at which the cells were treated. This process has the potential to increase the yield and reduce the production time for commercially useful secondary plant metabolites.

19.
J Pediatr ; 107(4): 514-20, 1985 Oct.
Article in English | MEDLINE | ID: mdl-2995630

ABSTRACT

During a 29-month period, we studied enteric infection in 70 families from a pediatric practice in suburban Washington, D.C. Fecal adenoviruses were detected in stools of 18 patients by tissue culture and electron microscopic procedures. From 6 through 11 months of age, the incidence of fecal adenoviruses associated with enteritis was seven per 100, and of confirmed enteric adenoviruses (EAds), three per 100 individuals per year. All EAds belonged to subgenus G (type 41). All three patients with EAds had diarrhea; two had vomiting and one had fever, but none required hospitalization. Ten of the 15 patients with non-EAds were younger than 2 years, and 60% had diarrhea, 40% had vomiting, and 20% had fever. Combined gastrointestinal and respiratory symptoms occurred more often in those who shed non-EAds (three of 11) than in matched controls (two of 48, P = 0.04). An adenovirus was detected in approximately 6% of gastroenteritis episodes, and confirmed EAds were present in approximately 2% of episodes of gastroenteritis in children younger than 2 years of age. None of the contacts of patients with non-EAds shed such virus in their stools. None of nine family contacts of those with EAd appeared to shed adenovirus in stool. In contrast, rotavirus spread readily to exposed adults (25% of 65) and children (56% of 62) when a child in similar families had rotavirus infection.


Subject(s)
Adenoviridae Infections/epidemiology , Adenoviridae/isolation & purification , Feces/microbiology , Gastroenteritis/etiology , Adolescent , Adult , Age Factors , Child , Child, Preschool , Diarrhea, Infantile/epidemiology , Diarrhea, Infantile/etiology , District of Columbia , Gastroenteritis/epidemiology , Humans , Infant , Infant, Newborn , Longitudinal Studies , Maryland , Microbiological Techniques , Virginia
20.
Plant Cell Rep ; 3(4): 161-4, 1984 Aug.
Article in English | MEDLINE | ID: mdl-24253477

ABSTRACT

Pre-existing methods for measuring cell or organelle volume based on the selective permeability of biological membranes have been modified to make them suitable for determining the intracellular volume of immoblised cells. When a freely permeable substance (e.g. tritiated water) and an impermeable substance ((14)C labelled mannitol is often suitable) are mixed with an immobilised cell culture, the two substances are diluted to different degrees. The extent of the difference allows the total intracellular volume of intact cells to be calculated. This volume is shown to be a useful parameter for assessing cell growth. The application of the method to follow membrane integrity and cell viability is also discussed.

SELECTION OF CITATIONS
SEARCH DETAIL
...